HIV/AIDS

HIV/AIDS
Field	Infectious disease, Immunology

HIV/AIDS. HIV/AIDS is a spectrum of conditions caused by infection with the human immunodeficiency virus, a retrovirus that attacks the immune system. The most advanced stage of infection is acquired immunodeficiency syndrome, which allows life-threatening opportunistic infections and cancers to thrive. Since the beginning of the epidemic, it has resulted in tens of millions of deaths globally, making it one of the most significant public health challenges in modern history.

Overview

The virus primarily targets vital cells in the human immune system, such as helper T cells, specifically CD4+ T cells, macrophages, and dendritic cells. This progressive depletion of CD4+ T cells severely compromises the body's ability to fight infections. Without intervention, the infection advances through distinct clinical stages, from acute infection to a prolonged asymptomatic period, culminating in the profound immunosuppression characteristic of AIDS. The development of AIDS is defined by specific criteria, including a low CD4+ T cell count or the occurrence of certain opportunistic infections like Pneumocystis pneumonia or cancers such as Kaposi's sarcoma.

Transmission and prevention

The virus is transmitted through direct contact with certain bodily fluids, most commonly during unprotected sexual intercourse, shared use of contaminated hypodermic needles, and from mother to child during pregnancy, childbirth, or breastfeeding. Key prevention strategies include the consistent use of condoms, harm reduction programs like needle exchange programs, and pre-exposure prophylaxis for high-risk individuals. Major global initiatives, such as those led by the World Health Organization and the Joint United Nations Programme on HIV/AIDS, promote widespread testing and education campaigns. The work of organizations like the Centers for Disease Control and Prevention and the Bill & Melinda Gates Foundation has been instrumental in advancing prevention science and implementation.

Diagnosis and monitoring

Diagnosis is typically made through blood tests that detect antibodies, antigens, or viral RNA. Common screening assays include the ELISA test, with confirmation by Western blot or other supplemental tests. Following diagnosis, regular monitoring of CD4+ T cell counts and viral load measurements is critical for assessing disease progression and the effectiveness of therapy. The introduction of rapid point-of-care tests, championed by entities like the World Health Organization, has greatly expanded access to testing in resource-limited settings. Advanced diagnostic networks, including those supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria, are essential for managing the epidemic.

Treatment and management

The standard treatment is antiretroviral therapy, which uses a combination of drugs from several classes, such as nucleoside reverse transcriptase inhibitors, protease inhibitors, and integrase inhibitors, to suppress viral replication. Successful ART can reduce the viral load to undetectable levels, restoring immune function and preventing transmission, a concept known as Undetectable = Untransmittable. Management also includes treating and preventing opportunistic infections. Landmark research from institutions like the National Institutes of Health and pharmaceutical advancements from companies like Gilead Sciences have transformed the prognosis from fatal to a manageable chronic condition for many.

Epidemiology

The global pandemic has affected all regions, with a particularly severe impact in Sub-Saharan Africa. Significant prevalence also exists in regions including Eastern Europe, Central Asia, and Southeast Asia. As reported by the Joint United Nations Programme on HIV/AIDS, tens of millions of people are living with the virus worldwide. Key affected populations often include men who have sex with men, sex workers, people who inject drugs, and transgender individuals. International efforts, coordinated by the Global Fund to Fight AIDS, Tuberculosis and Malaria and the President's Emergency Plan for AIDS Relief, have been pivotal in expanding access to treatment and care.

History and society

The first recognized cases were reported in the United States in 1981 among previously healthy young men in Los Angeles and New York City. The virus was subsequently isolated by researchers including Luc Montagnier at the Pasteur Institute and Robert Gallo at the National Institutes of Health. The ensuing epidemic sparked widespread social stigma, discrimination, and activist movements, most notably the ACT UP organization. Cultural responses have been profound, reflected in works like the play Angels in America and the memorial AIDS Memorial Quilt. Scientific milestones, such as the development of the first antiretroviral drug zidovudine and the pioneering work of Anthony Fauci, have defined the medical battle against the disease.

Category:Infectious diseases Category:Public health Category:Viral diseases